Outcomes of buccinator treatment with botulinum toxin in facial synkinesis

JAMA Facial Plastic Surgery

Volumn 20, Issue 3, 2018, Pages 196-201

  Patel, Priyesh N ^a   Owen, Scott R ^a   Norton, Cathey P ^a   Emerson, Brandon T ^b   Bronaugh, Andrea B ^a   Ries, William R ^a   Stephan, Scott J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

DRUG EFFECT; FACE MUSCLE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; SYNKINESIS; TREATMENT OUTCOME;

BOTULINUM TOXINS, TYPE A; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; SYNKINESIS; TREATMENT OUTCOME;

EID: 85047745383     PISSN: 21686076     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamafacial.2017.1385     Document Type: Article

References (20)

1. Choi KH, Rho SH, Lee JM, Jeon JH, Park SY, Kim J. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg. 2013;66(8):1058-1063.
2. Fu L, Bundy C, Sadiq SA. Psychological distress in people with disfigurement from facial palsy. Eye (Lond). 2011;25(10):1322-1326.
3. Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope. 2012; 122(2):266-270.
4. Mehdizadeh OB, Diels J, White WM. Botulinum toxin in the treatment of facial paralysis. Facial Plast Surg Clin North Am. 2016;24(1):11-20.
5. Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg. 2008;24(2):242-249.
6. Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthal Plast Reconstr Surg. 2014;30(3): 246-250.
7. Chua CN, Quhill F, Jones E, Voon LW, Ahad M, Rowson N. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. 2004; 23(4):213-218.
8. Borodic GE, Pearce LB, Cheney M, et al. Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg. 1993;91(6): 1042-1045.
9. Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32(17):1414-1418.
10. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116(1):36-43.
11. Laskawi R, Damenz W, Roggenkämper P, Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol. 1994;S195-S199.
12. Rogers CR, Schmidt KL, VanSwearingen JM, et al. Automated facial image analysis: detecting improvement in abnormal facial movement after treatment with botulinum toxin A. Ann Plast Surg. 2007;58(1):39-47.
13. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope. 1996;106(12 Pt 1):1491-1496.
14. Wei LA, Diels J, Lucarelli MJ. Treating buccinator with botulinum toxin in patients with facial synkinesis: a previously overlooked target. Ophthal Plast Reconstr Surg. 2016;32(2):138-141.
15. Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope. 2007;117(5):923-926.
16. Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci. 1996;21(1):15-20.
17. Dall’Angelo A, Mandrini S, Sala V, et al. Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope. 2014;124(11):2513-2517.
18. On AY, Yaltirik HP, Kirazli Y. Agreement between clinical and electromyographic assessments during the course of peripheric facial paralysis. Clin Rehabil. 2007;21(4):344-350.
19. Chundury RV, Perry JD. Re: “Treating buccinator with botulinum toxin in patients with facial synkinesis: a previously overlooked target.” Ophthal Plast Reconstr Surg. 2016;32(1):70.
20. Fattah AY, Gurusinghe AD, Gavilan J, et al; Sir Charles Bell Society. Facial nerve grading instruments: systematic review of the literature and suggestion for uniformity. Plast Reconstr Surg. 2015;135(2):569-579.